올리고뉴클레오티드 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2024-2034년)
Oligonucleotides Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034
상품코드:1624346
리서치사:Transparency Market Research
발행일:2024년 11월
페이지 정보:영문 172 Pages
라이선스 & 가격 (부가세 별도)
한글목차
올리고뉴클레오타이드 시장 - 조사 범위
TMR의 세계 올리고뉴클레오타이드 시장 조사 보고서는 2024년부터 2034년까지의 예측 기간 동안 시장 지표에 대한 귀중한 통찰력을 얻기 위해 과거뿐만 아니라 현재의 성장 동향과 기회도 조사했습니다. 이 보고서는 2024년을 기준 연도, 2034년을 예측 연도로 하여 2018년부터 2034년까지 세계 올리고뉴클레오타이드 시장의 수익과 예측을 제공합니다. 또한 2024년부터 2034년까지 세계 올리고뉴클레오타이드 시장의 연평균 성장률(CAGR%)도 제시합니다.
이 보고서는 광범위한 조사를 통해 작성되었으며, 1차 조사는 애널리스트가 KOL(Key Opinion Leader), 업계 리더 및 오피니언 제조업체를 인터뷰하고, 2차 조사는 주요 기업의 제품 자료, 연례 보고서, 보도 자료, 관련 자료를 참조하여 올리고뉴클레오티드 시장을 추론했습니다, 올리고뉴클레오타이드 시장을 추론했습니다.
시장 현황
2023년 시장 매출
3.7억 달러
2034년 시장 매출
131억 달러
CAGR
11.9%
이 보고서는 세계 올리고뉴클레오타이드 시장의 경쟁 환경을 조사했습니다. 세계 올리고뉴클레오타이드 시장에서 활동하는 주요 기업들이 확인되었으며, 각 기업들은 다양한 속성으로 프로파일링되었습니다. 기업 개요, 재무 상태, 최근 동향, SWOT는 세계 올리고뉴클레오타이드 시장 기업의 속성으로 이 보고서에서 소개됩니다.
목차
제1장 서문
제2장 전제조건과 조사 방법
제3장 주요 요약 : 세계 시장
제4장 시장 개요
서론
개요
시장 역학
세계 시장 분석과 예측, 2020년-2034년
제5장 주요 인사이트
세계에서 개발되고 있는 수 : 주요 지역별
인기 상품 리스트
가격 분석
시장 진출 전략
최종사용자에 있어서의 중요 구입 지표
PESTEL 분석
주요 업계 이벤트
Porter의 Five Forces 분석
주요 국가, 지역별 규제 시나리오
제품/브랜드 분석
유통업체 상황
기술적 진보
자금조달/투자 시나리오
시장에 관한 제안과 애널리스트의 견해
제6장 세계 시장 분석과 예측 : 유형별
서론과 정의
주요 조사 결과/발전
시장 매출 예측 : 유형별, 2020년-2034년
안티센스
DNA
siRNA
기타(CpG)
시장의 매력 : 유형별
제7장 세계 시장 분석과 예측 : 용도별
서론과 정의
주요 조사 결과/발전
시장 매출 예측 : 용도별, 2020년-2034년
분자생물학
유전자 치료
의약품 개발
진단
기타(나노테크놀러지, 조사 조사등)
시장의 매력 : 용도별
제8장 세계 시장 분석과 예측 : 최종사용자별
서론과 정의
주요 조사 결과/발전
시장 매출 예측 : 최종사용자별, 2020년-2034년
병원
제약 및 바이오의약품 기업
진단 실험실
바이오테크놀러지 기업
CRO와 CMO
기타(학술연구기관 등)
시장의 매력 : 최종사용자별
제9장 세계 시장 분석과 예측 : 지역별
주요 조사 결과
시장 매출 예측 : 지역별
북미
유럽
아시아태평양
라틴아메리카
중동 및 아프리카
국가/지역별 시장의 매력
제10장 북미 시장 분석과 예측
미국
캐나다
제11장 유럽 시장 분석과 예측
독일
영국
프랑스
이탈리아
스페인
기타 유럽
제12장 아시아태평양 시장 분석과 예측
중국
인도
일본
호주 및 뉴질랜드
기타 아시아태평양
제13장 라틴아메리카 시장 분석과 예측
브라질
멕시코
기타 라틴아메리카
제14장 중동 및 아프리카 시장 분석과 예측
남아프리카공화국
GCC 국가
기타 중동 및 아프리카
제15장 경쟁 구도
시장 기업 - 경쟁 매트릭스(기업 Tier과 규모별)
시장 점유율 분석 : 기업별(2023년)
기업 개요
Agilent Technologies
Ajinomoto Bio-Pharma Services
CordenPharma
Creative Biolabs
Ella Biotech
Eurofins Genomics
Future synthesis
Integrated DNA Technologies
Kaneka Eurogentec
Thermo Fisher Scientific Inc.
Merck
Microsynth
Nitto Avecia
LSH
영문 목차
영문목차
Oligonucleotides Market - Scope of Report
TMR's report on the global oligonucleotides market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global oligonucleotides market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global oligonucleotides market from 2024 to 2034.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the oligonucleotides market.
Market Snapshot
Market Value in 2023
US$ 3.7 Bn
Market Value in 2034
US$ 13.1 Bn
CAGR
11.9%
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global oligonucleotides market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global oligonucleotides market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global oligonucleotides market.
The report delves into the competitive landscape of the global oligonucleotides market. Key players operating in the global oligonucleotides market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global oligonucleotides market profiled in this report.
Key Questions Answered in Global oligonucleotides Market Report:
What is the sales/revenue generated by oligonucleotides across all regions during the forecast period?
What are the opportunities in the global oligonucleotides market?
What are the major drivers, restraints, opportunities, and threats in the market?
Which regional market is set to expand at the fastest CAGR during the forecast period?
Which segment is expected to generate the highest revenue globally in 2034?
Which segment is projected to expand at the highest CAGR during the forecast period?
What are the market positions of different companies operating in the global market?
Oligonucleotides Market - Research Objectives and Research Approach
The comprehensive report on the global oligonucleotides market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global oligonucleotides market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global oligonucleotides market.
Table of Contents
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary : Global Oligonucleotides Market
4. Market Overview
4.1. Introduction
4.1.1. Segmentation Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Oligonucleotides Market Analysis and Forecasts, 2020-2034
4.4.1. Market Revenue Projections (US$ Bn)
5. Key Insights
5.1. No. of Oligonucleotides being developed in world by Key Regions
5.2. List of top Oligonucleotides products
5.3. Pricing Analysis
5.4. Go-to-Market Strategy
5.5. Key Purchase Metrics for End-users
5.6. PESTEL Analysis
5.7. Key Industry Events
5.8. Porter's Five Forces Analysis
5.9. Regulatory Scenario by Key Countries/Regions
5.10. Product/Brand Analysis
5.11. Distributors Landscape
5.12. Technological Advancements
5.13. Fund Raise/Investment Scenario
5.14. Recommendations and Analyst View for the Market
6. Global Oligonucleotides Market Analysis and Forecasts, By Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast By Type, 2020-2034
6.3.1. Antisense Oligonucleotides
6.3.2. DNA
6.3.3. siRNA
6.3.4. Others (CpG Oligonucleotides)
6.4. Market Attractiveness By Type
7. Global Oligonucleotides Market Analysis and Forecasts, By Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast By Application, 2020-2034
7.3.1. Molecular Biology
7.3.2. Gene Therapy
7.3.3. Drug Development
7.3.4. Diagnostics
7.3.5. Others (Nanotechnology, Research studies etc.)
7.4. Market Attractiveness By Application
8. Global Oligonucleotides Market Analysis and Forecasts, By End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast By End-user, 2020-2034
8.3.1. Hospitals
8.3.2. Pharma & Biopharma Companies
8.3.3. Diagnostic Laboratories
8.3.4. Biotechnology Companies
8.3.5. CROs and CMOs
8.3.6. Others (Academic Research Institutes, etc.)
8.4. Market Attractiveness By End-user
9. Global Oligonucleotides Market Analysis and Forecasts, By Region
9.1. Key Findings
9.2. Market Value Forecast By Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness By Country/Region
10. North America Oligonucleotides Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast By Type, 2020-2034
10.2.1. Antisense Oligonucleotides
10.2.2. DNA
10.2.3. siRNA
10.2.4. Others (CpG Oligonucleotides)
10.3. Market Value Forecast By Application, 2020-2034
10.3.1. Molecular Biology
10.3.2. Gene Therapy
10.3.3. Drug Development
10.3.4. Diagnostics
10.3.5. Others (Nanotechnology, Research studies etc.)
10.4. Market Value Forecast By End-user, 2020-2034
10.4.1. Hospitals
10.4.2. Pharma & Biopharma Companies
10.4.3. Diagnostic Laboratories
10.4.4. Biotechnology Companies
10.4.5. CROs and CMOs
10.4.6. Others (Academic Research Institutes, etc.)
10.5. Market Value Forecast By Country, 2020-2034
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Type
10.6.2. By Application
10.6.3. By End-user
10.6.4. By Country
11. Europe Oligonucleotides Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast By Type, 2020-2034
11.2.1. Antisense Oligonucleotides
11.2.2. DNA
11.2.3. siRNA
11.2.4. Others (CpG Oligonucleotides)
11.3. Market Value Forecast By Application, 2020-2034
11.3.1. Molecular Biology
11.3.2. Gene Therapy
11.3.3. Drug Development
11.3.4. Diagnostics
11.3.5. Others (Nanotechnology, Research studies etc.)
11.4. Market Value Forecast By End-user, 2020-2034
11.4.1. Hospitals
11.4.2. Pharma & Biopharma Companies
11.4.3. Diagnostic Laboratories
11.4.4. Biotechnology Companies
11.4.5. CROs and CMOs
11.4.6. Others (Academic Research Institutes, etc.)
11.5. Market Value Forecast By Country/Sub-region, 2020-2034
11.5.1. Germany
11.5.2. UK
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Type
11.6.2. By Application
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Oligonucleotides Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast By Type, 2020-2034
12.2.1. Antisense Oligonucleotides
12.2.2. DNA
12.2.3. siRNA
12.2.4. Others (CpG Oligonucleotides)
12.3. Market Value Forecast By Application, 2020-2034
12.3.1. Molecular Biology
12.3.2. Gene Therapy
12.3.3. Drug Development
12.3.4. Diagnostics
12.3.5. Others (Nanotechnology, Research studies etc.)
12.4. Market Value Forecast By End-user, 2020-2034
12.4.1. Hospitals
12.4.2. Pharma & Biopharma Companies
12.4.3. Diagnostic Laboratories
12.4.4. Biotechnology Companies
12.4.5. CROs and CMOs
12.4.6. Others (Academic Research Institutes, etc.)
12.5. Market Value Forecast By Country/Sub-region, 2020-2034
12.5.1. China
12.5.2. India
12.5.3. Japan
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Type
12.6.2. By Application
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Oligonucleotides Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast By Type, 2020-2034
13.2.1. Antisense Oligonucleotides
13.2.2. DNA
13.2.3. siRNA
13.2.4. Others (CpG Oligonucleotides)
13.3. Market Value Forecast By Application, 2020-2034
13.3.1. Molecular Biology
13.3.2. Gene Therapy
13.3.3. Drug Development
13.3.4. Diagnostics
13.3.5. Others (Nanotechnology, Research studies etc.)
13.4. Market Value Forecast By End-user, 2020-2034
13.4.1. Hospitals
13.4.2. Pharma & Biopharma Companies
13.4.3. Diagnostic Laboratories
13.4.4. Biotechnology Companies
13.4.5. CROs and CMOs
13.4.6. Others (Academic Research Institutes, etc.)
13.5. Market Value Forecast By Country/Sub-region, 2020-2034
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of LATAM
13.6. Market Attractiveness Analysis
13.6.1. By Type
13.6.2. By Application
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Oligonucleotides Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast By Type, 2020-2034
14.2.1. Antisense Oligonucleotides
14.2.2. DNA
14.2.3. siRNA
14.2.4. Others (CpG Oligonucleotides)
14.3. Market Value Forecast By Application, 2020-2034
14.3.1. Molecular Biology
14.3.2. Gene Therapy
14.3.3. Drug Development
14.3.4. Diagnostics
14.3.5. Others (Nanotechnology, Research studies etc.)
14.4. Market Value Forecast By End-user, 2020-2034
14.4.1. Hospitals
14.4.2. Pharma & Biopharma Companies
14.4.3. Diagnostic Laboratories
14.4.4. Biotechnology Companies
14.4.5. CROs and CMOs
14.4.6. Others (Academic Research Institutes, etc.)
14.5. Market Value Forecast By Country/Sub-region, 2020-2034
14.5.1. South Africa
14.5.2. GCC Countries
14.5.3. Rest of MEA
14.6. Market Attractiveness Analysis
14.6.1. By Type
14.6.2. By Application
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competition Matrix (By Tier and Size of companies)
15.2. Market Share Analysis By Company (2023)
15.3. Company Profiles
15.3.1. Agilent Technologies
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Product Portfolio
15.3.1.3. Financial Overview
15.3.1.4. SWOT Analysis
15.3.1.5. Strategic Overview
15.3.2. Ajinomoto Bio-Pharma Services
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Product Portfolio
15.3.2.3. Financial Overview
15.3.2.4. SWOT Analysis
15.3.2.5. Strategic Overview
15.3.3. CordenPharma
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Product Portfolio
15.3.3.3. Financial Overview
15.3.3.4. SWOT Analysis
15.3.3.5. Strategic Overview
15.3.4. Creative Biolabs
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Product Portfolio
15.3.4.3. Financial Overview
15.3.4.4. SWOT Analysis
15.3.4.5. Strategic Overview
15.3.5. Ella Biotech
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Product Portfolio
15.3.5.3. Financial Overview
15.3.5.4. SWOT Analysis
15.3.5.5. Strategic Overview
15.3.6. Eurofins Genomics
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Product Portfolio
15.3.6.3. Financial Overview
15.3.6.4. SWOT Analysis
15.3.6.5. Strategic Overview
15.3.7. Future synthesis
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Product Portfolio
15.3.7.3. Financial Overview
15.3.7.4. SWOT Analysis
15.3.7.5. Strategic Overview
15.3.8. Integrated DNA Technologies
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Product Portfolio
15.3.8.3. Financial Overview
15.3.8.4. SWOT Analysis
15.3.8.5. Strategic Overview
15.3.9. Kaneka Eurogentec
15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.9.2. Product Portfolio
15.3.9.3. Financial Overview
15.3.9.4. SWOT Analysis
15.3.9.5. Strategic Overview
15.3.10. Thermo Fisher Scientific Inc.
15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.10.2. Product Portfolio
15.3.10.3. Financial Overview
15.3.10.4. SWOT Analysis
15.3.10.5. Strategic Overview
15.3.11. Merck
15.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.11.2. Product Portfolio
15.3.11.3. Financial Overview
15.3.11.4. SWOT Analysis
15.3.11.5. Strategic Overview
15.3.12. Microsynth
15.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.12.2. Product Portfolio
15.3.12.3. Financial Overview
15.3.12.4. SWOT Analysis
15.3.12.5. Strategic Overview
15.3.13. Nitto Avecia
15.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
